| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/24/2008 | US20080175837 Autophagy regulators; drug screening; dipeptidyl peptidase IV (Dpp4); preservative of organs for transplantation |
| 07/24/2008 | US20080175835 A beta -derived diffusible ligands (ADDL) specific immunoglobulin for use in prevention and treatment of alzheimer's diseases |
| 07/24/2008 | US20080175831 Neuroprotection by blood flow stabilization |
| 07/24/2008 | US20080175828 Proliferated cell lines and uses thereof |
| 07/24/2008 | US20080175819 Vector system |
| 07/24/2008 | US20080175796 Delivery of Drug Esters Through an Inhalation Route |
| 07/24/2008 | US20080175794 Substituted Pyridazinyl- and Pyrimidinyl-Quinolin-4-Ylamine Analogues |
| 07/24/2008 | US20080175789 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits |
| 07/24/2008 | DE102007002717A1 Heterocyclische Indazolderivate Heterocyclic indazole derivatives |
| 07/24/2008 | DE102007002715A1 Triazolderivat Triazole derivative |
| 07/24/2008 | CA2676432A1 Inhibitors of d-amino acid oxidase |
| 07/24/2008 | CA2675847A1 Pegylated a.beta. fab |
| 07/24/2008 | CA2675733A1 Method for glycosylation of flavonoid compounds |
| 07/24/2008 | CA2675676A1 Nicotinic acetylcholine receptor modulators |
| 07/24/2008 | CA2675419A1 Heterocyclic-substituted piperidine compounds and the uses thereof |
| 07/24/2008 | CA2674865A1 Indole derivative having i.kappa.b kinase .beta. inhibitory activity |
| 07/24/2008 | CA2674678A1 Morpholine dopamine agonists for the treatment of pain |
| 07/24/2008 | CA2674303A1 Therapeutical uses of eslicarbazepine |
| 07/24/2008 | CA2673485A1 Gastric retention-type sustained-release levodopa preparation |
| 07/24/2008 | CA2672425A1 Galenic form for the transmucosal delivery of paracetamol |
| 07/23/2008 | EP1947093A1 Substituted morpholine and thiomorpholine derivatives |
| 07/23/2008 | EP1946774A1 Cerebral infarction-preventive agent |
| 07/23/2008 | EP1946767A2 Autologous T-cell vaccines against multiple sclerosis |
| 07/23/2008 | EP1946763A1 Promoter for recovery from anesthesia |
| 07/23/2008 | EP1945639A1 Tetrahydronaphthyridine derivative |
| 07/23/2008 | EP1945638A2 Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-but oxy]-3,4-dihydro-1h-[1,8]naphthyridin-2-one |
| 07/23/2008 | EP1945635A2 Thiazolyl piperidine derivatives useful as h3 receptor modulators |
| 07/23/2008 | EP1945633A1 Compounds and compositions as ppar modulators |
| 07/23/2008 | EP1945630A2 Pyrazine derivatives as sodium channel modulators for the treatment of pain |
| 07/23/2008 | EP1945628A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 07/23/2008 | EP1945624A1 Chroman compounds as 5-ht1b antagonists |
| 07/23/2008 | EP1945259A2 Fusion proteins for blood-brain barrier delivery |
| 07/23/2008 | EP1945230A1 Anti-misuse microparticulate oral pharmaceutical form |
| 07/23/2008 | EP1945226A2 Drug composition with analgesic, anti-inflammatory and decongestive activity |
| 07/23/2008 | EP1945220A1 Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists |
| 07/23/2008 | EP1945213A2 3-piperidin-4-yl-indole orl-1 receptor modulators |
| 07/23/2008 | EP1945186A2 Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent |
| 07/23/2008 | EP1868625B1 Improved method for preparing ginkgo extracts having a low content of 4'-o-methyl pyridoxine and/or biflavones |
| 07/23/2008 | EP1846384B1 Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine |
| 07/23/2008 | EP1827427B1 Aryloxyethylamine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 07/23/2008 | EP1601349B1 Use of the enantiomer (1s, 2r) of milnacipran for the preparation of a medicament |
| 07/23/2008 | EP1587506B1 Administration of capsaicinoids |
| 07/23/2008 | EP1565464B1 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 07/23/2008 | EP1562572B1 Pharmaceutical Solid Dispersions of Modafinil Compounds |
| 07/23/2008 | EP1549633B1 Nicotine-containing, controlled release composition and method |
| 07/23/2008 | EP1513535B1 Controlled release formulation of lamotrigine |
| 07/23/2008 | EP1503771B1 Sedative materials and treatments |
| 07/23/2008 | EP1490367B1 Imidazopyridine derivatives as kinase inhibitors |
| 07/23/2008 | EP1471901B1 Spermidine derivative for the treatment of chronic neurodegenerative diseases |
| 07/23/2008 | EP1412361B1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 07/23/2008 | EP1372696B1 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 07/23/2008 | EP1342723B1 Indole derivatives and use thereof in medicines |
| 07/23/2008 | EP1325745B1 Preventives and remedies for complications of diabetes |
| 07/23/2008 | EP1294382B1 7-hydroxyepiandrosterone having neuroprotective activity |
| 07/23/2008 | EP1272167B1 Ropinirole-containing hydrophilic/liphilic polymeric matrix dosage formulation |
| 07/23/2008 | EP1246797B1 Cyclopentyl sulfonamide derivatives |
| 07/23/2008 | EP1242091B1 Use of pharmaceutical compositions comprising oxcarbazepine in the fasted state |
| 07/23/2008 | EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/23/2008 | EP1163271B1 Recombinant il-18 antibodies and their use |
| 07/23/2008 | EP1141241B1 Adult human astrocytes, preparation of the same, and uses thereof |
| 07/23/2008 | EP1126830B1 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 07/23/2008 | EP1073638B1 Heterocyclically substituted amides, their production and their use |
| 07/23/2008 | EP1071680B1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 07/23/2008 | EP1047416B1 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/23/2008 | EP0957914B2 Formulation of 5-ht agonists |
| 07/23/2008 | CN101228163A Aspartyl protease inhibitors |
| 07/23/2008 | CN101228158A N-amide derivatives of 8-azabicyclo[3.2.1]oct-3-yl as ccr1 antagonists |
| 07/23/2008 | CN101228155A Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 07/23/2008 | CN101228146A Benzofuran derivatives with therapeutic activities |
| 07/23/2008 | CN101228137A Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists |
| 07/23/2008 | CN101228130A Aryloxy quinolines and uses as 5-HT6 thereof |
| 07/23/2008 | CN101228121A Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5HT6 receptor |
| 07/23/2008 | CN101228119A Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5HT6 receptor |
| 07/23/2008 | CN101227901A Anti-inflammatory agents |
| 07/23/2008 | CN101226199A Effect of N-methyl-D-asparagic acid acceptor in epilepsy generation |
| 07/23/2008 | CN101224278A Medicine compounds for treating primary trigeminal neuralgia and preparing method thereof |
| 07/23/2008 | CN101224260A Health product compounds consisting of lecithin, grape seed extract and ginkgo leaf extract |
| 07/23/2008 | CN101224247A Chinese traditional medicine compounds for treating Alzheimer's disease and preparing method thereof |
| 07/23/2008 | CN101224225A Preparing method of hypericum perforatum extract |
| 07/23/2008 | CN101224212A Ferulic acid and sodium salt for preparing medicine used to prevent and treat tristimania |
| 07/23/2008 | CN101224208A Uses of tandospirone and derivative thereof in improving memory and cognitive uses |
| 07/23/2008 | CN101224201A Application of dual inhibitor for dopamine and norepinephrine transfer protein |
| 07/23/2008 | CN101224078A Silk pillow capable of permanently sending out tea perfume and producing method thereof |
| 07/23/2008 | CN101223988A Healthy drink for anti-alcoholic, protecting liver, invigorating the spleen and nourishing stomach and preparing method thereof |
| 07/23/2008 | CN100405062C Therapeutic and diagnostic uses of antibody specificity profiles |
| 07/23/2008 | CN100404540C Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting prot ein kinases |
| 07/23/2008 | CN100404536C Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 07/23/2008 | CN100404533C New quinuclidine amide derivatives |
| 07/23/2008 | CN100404514C 2-substituted phenyl-4,4,5,5-tetramethyl-1,3,-dioxy imidazolines, their preparation and pharmaceutical use |
| 07/23/2008 | CN100404489C Method for extracting hypericin |
| 07/23/2008 | CN100404040C Medicinal composition for treating cardiopathy and its preparation method and use |
| 07/23/2008 | CN100404038C A health product of lucid ganoderma and preparation method thereof |
| 07/23/2008 | CN100404025C Oral disintegrating tablet containing tramadol hydrochloride and acetaminopher, and its preparation method |
| 07/23/2008 | CN100404021C Medical super fire micro capsule capsaicine and its preparing method |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402682 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
| 07/22/2008 | US7402605 E.g., 17,17-propano-16-hydroxy-5-(4-ethoxycarbonylthiazol-2-yl)-9-oxo-1,2,3,4,20-pentanor-5-thia-8-azaprost-13-ene; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 07/22/2008 | US7402604 4-oxy- or amino-substituted indole-2-carboxy acids, esters and amides, e.g., N-(2-hydroxy-1-phenylethyl) 4-hydroxy-1-methyl-1H-indole-2-carboxamide; nicotinic receptor agonist; conditions associated with reductions in nicotinic transmission; Alzheimer's disease, anxiety or schizophrenia |
| 07/22/2008 | US7402602 Imidazole derivatives modulating the sodium channels |
| 07/22/2008 | US7402600 Nitroderivatives of cardiovascular agents |